ST. PANCRAS CLINICAL RESEARCH LTD.Active
Key figures
Like most small UK companies, ST. PANCRAS CLINICAL RESEARCH LTD. does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 96,269 | 10,587 | 389,423 | 588,545 | 1,072,995 |
| Total assets | 917,008 | 1,121,997 | 2,066,333 | 1,441,127 | 2,620,919 |
| Total liabilities | 1,934,622 | 1,912,492 | 2,143,613 | 1,227,544 | 1,513,198 |
| Net assets / total equity | -847,489 | -725,212 | -81,672 | 208,874 | 1,077,766 |
| Average number of employees | 27 | 30 | 30 | 28 | 32 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025Specialist medical practice
As described in the company's latest filed accounts.
Summary: ST. PANCRAS CLINICAL RESEARCH LTD.
Company
ST. PANCRAS CLINICAL RESEARCH LTD. is a private limited company registered with Companies House under company number 10099653. It was incorporated on 4 Apr 2016. Its status is active. The registered office is in London (EC2Y). Its nature of business (SIC 2007) is specialists medical practice activities (86220).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files small company accounts (filleted). Net assets were £1,077,766, up 416% on the previous year. Cash at bank and in hand was £1,072,995. Total assets were £2,620,919 and total liabilities £1,513,198. The company had an average of 32 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 9 Apr 2027.